Quantification of perineural cancer invasion on systematic needle core biopsy of the prostate is useful for risk stratification in patients with Grade Group 2 or 3 cancer, but not in those with Grade Group 4-5 cancer

被引：0
|
作者：
Teramoto, Y. [1 ]
Wang, Y. [1 ]
Miyamoto, H. [2 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY USA
[2] Univ Rochester, Med Ctr, Dept Pathol & Urol, Rochester, NY USA
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0288
引用
收藏
页码：S1080 / S1081
页数：2
相关论文
共 50 条
  • [41] Clinical analysis of EV-Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
    Fairey, Adrian
    Paproski, Robert J.
    Pink, Desmond
    Sosnowski, Deborah L.
    Vasquez, Catalina
    Donnelly, Bryan
    Hyndman, Eric
    Aprikian, Armen
    Kinnaird, Adam
    Beatty, Perrin H.
    Lewis, John D.
    CANCER MEDICINE, 2023, 12 (15): : 15797 - 15808
  • [42] Re: Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center
    Shah, Navin
    Ioffe, Vladimir
    JOURNAL OF UROLOGY, 2020, 204 (05): : 1063 - 1064
  • [43] Utility of multiparametric magnetic resonance imaging in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance
    Mamawala, Mufaddal K.
    Meyer, Alexa R.
    Landis, Patricia K.
    Macura, Katarzyna J.
    Epstein, Jonathan I.
    Partin, Alan W.
    Carter, Ballentine H.
    Gorin, Michael A.
    BJU INTERNATIONAL, 2020, 125 (06) : 861 - 866
  • [44] Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer EDITORIAL COMMENT
    Punnen, Sanoj
    JOURNAL OF UROLOGY, 2019, 201 (01): : 83 - 83
  • [45] Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
    Jacob Fredsøe
    Martin Rasmussen
    Amy L. Tin
    Andrew J. Vickers
    Michael Borre
    Karina D. Sørensen
    Hans Lilja
    Scientific Reports, 12
  • [46] Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
    Fredsoe, Jacob
    Rasmussen, Martin
    Tin, Amy L.
    Vickers, Andrew J.
    Borre, Michael
    Sorensen, Karina D.
    Lilja, Hans
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] RISKS OF GRADE RECLASSIFICATION AMONG PATIENTS WITH GLEASON GRADE GROUP 1 PROSTATE CANCER AND PI-RADS 5 FINDINGS ON PROSTATE MRI
    Sundaresan, Vinaik Mootha
    Webb, Lindsey
    Rabil, Maximilian
    Golos, Aleksandra
    Sutherland, Ryan
    Sprenkle, Preston
    Kim, Isaac
    Leapman, Michael
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S79 - S79
  • [48] Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI
    Sundaresan, Vinaik Mootha
    Webb, Lindsey
    Rabil, Maximilian
    Golos, Aleksandra
    Sutherland, Ryan
    Bailey, Jonell
    Rajwa, Pawel
    Seibert, Tyler M.
    Loeb, Stacy
    Cooperberg, Matthew R.
    Catalona, William J.
    Sprenkle, Preston C.
    Kim, Isaac Y.
    Leapman, Michael S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 193e19 - 193e26
  • [49] MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer
    Boschheidgen, M.
    Schimmoeller, L.
    Radtke, J. P.
    Kastl, R.
    Jannusch, K.
    Lakes, J.
    Drewes, L. R.
    Radke, K. L.
    Esposito, I.
    Albers, P.
    Antoch, G.
    Ullrich, T.
    Al-Monajjed, R.
    EUROPEAN RADIOLOGY, 2025, 35 (04) : 2170 - 2179
  • [50] Significant Survival Differences for Grade Group 4 and Grade Group 5 Prostate Cancer: Detailed Reporting of Pathohistology and Modern Diagnostic Algorithms Are Needed To Tailor Treatment
    Heidenreich, Axel
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (02): : 211 - 212
12345